Background {#Sec1}
==========

*Acanthamoeba* is a genus of ubiquitous free-living microorganisms that can cause *Acanthamoeba* keratitis (AK), a painful and severe sight threatening corneal disease. AK is especially prevalent among contact lens users, which corresponds to 85--88% of the AK cases \[[@CR1]\]. Since the first report of AK in 1973, the number of AK cases has increased concomitantly with the growing number of contact lens users \[[@CR2], [@CR3]\]. In Chile, up to 18 patients are diagnosed per year at the Public Health Institute of Chile \[[@CR4]\].

*Acanthamoeba* spp. are usually classified on the basis of the nuclear small subunit *18S* ribosomal RNA full gene sequence (*Rns*), which allows the differentiation of *Acanthamoeba* spp. into 20 genotypes (T1-T20) \[[@CR5]--[@CR7]\]. Since the complete *Rns* gene exceeds 2000 nucleotides, a 423 to 551 bp fragment named as "*Acanthamoeba* specific amplimer (ASA.S1)" within the *Rns* gene is used for genotyping *Acanthamoeba* spp. \[[@CR8]\]. A small but highly variable region inside ASA.S1 designated as DF3 (Diagnostic Fragment 3, ≈ 240 nucleotides long) is also used to determine the genotype of an isolate \[[@CR9]\]. Since the vast majority of AK cases worldwide are caused by *Acanthamoeba* genotype T4, information below the DF3 level is sufficient to establish a sub-genotype or variant \[[@CR6], [@CR10]--[@CR12]\].

*Acanthamoeba* genotyping is not only necessary for taxonomic purposes but also for epidemiological and clinical studies. It also provides valuable information for the development of new diagnostic methods, helps in selecting appropriate strains for the obtention of antigen, protein profile characterization, etc. Furthermore, it is possible to identify correlations between the isolates and clinically relevant aspects such as virulence, drug susceptibility and/or clinical outcome \[[@CR13]\].

All samples from patients with suspected AK in Chile are analyzed at the Public Health Institute of Chile (ISPCh). The samples are investigated by culture, and positive cultures are subjected to genotyping. The aim of the present study was to determine the prevailing genotypes of *Acanthamoeba* in AK infection in Chilean patients. To the best of our knowledge, this is the first study of this nature in Chile and one of the few performed in South America.

Methods {#Sec2}
=======

Collection of clinical specimens {#Sec3}
--------------------------------

The samples received for *Acanthamoeba* diagnosis at the ISPCh were processed as described previously \[[@CR4]\]. Briefly, the samples were inoculated onto 2% non-nutrient agar plates overlaid with 100 μl of a liquid culture of *Escherichia coli* in Page's solution (NNA-*E. coli*). The plates were incubated at 37 °C for seven days and examined daily under a conventional light microscope for the presence of trophozoites and/or cyst. All positive culture plates were routinely collected in Page's solution, subcultured in 5 ml Petri dishes with NNA overlaid with live *E. coli*, and also diluted 1:2 with sterile glycerol for long term storage at -20 °C. Amoebas from subculture plates were harvested and rinsed three times in phosphate-buffered saline (pH 7.4) and then transferred to Eppendorf tubes for further molecular analysis. When the genotyping service was not readily accessible, the samples were stored frozen until the service became available. At that time, an aliquot of the frozen stock was inoculated onto NNA overlaid with live *E. coli* until growth was observed. Then, the samples of amoeba were collected and processed for molecular analysis as described above.

DNA extraction and PCR amplification assay {#Sec4}
------------------------------------------

*Acanthamoeba* trophozoites and cysts were lysed by thermal shock at 56 °C for 15 min with proteinase K; DNA was then extracted using a QIAamp DNA Mini Kit ® (Qiagen, Venlo, NLD) following the manufacturer's protocol.

The ASA.S1 region in *Rns* was amplified using the *Acanthamoeba* genus-specific primers, forward JDP1 (5\'-GGC CCA GAT CGT TTA CCG TGA A-3\') and reverse JDP2 (5\'-TCT CAC AAG CTG CTA GGG GAG TCA-3\') as described by Booton et al. \[[@CR10]\]. These primers amplified a fragment of approximately 500 bp. The PCR reactions were set up to a final volume of 50 μl, using 30 ng DNA, 1× amplification buffer \[10 mM Tris-HCl (pH 9.0), 3.5 mM MgCl~2~\], 2 mM of each dNTP, 20 μM of each primer, 1.25 U Taq DNA polymerase and distilled water to make the volume. Amplification cycles were performed in a GeneAmp System 2700 thermocycler (Applied Biosystems, Foster City, CA, USA). The PCR cycles were set up as follows: pre-denaturation step at 94 °C for 3 min and 35 cycles of denaturation at 94 °C for 30 s, 60 °C of annealing for 30 s and then 72 °C for 1 min, followed by a final elongation step of 72 °C for 5 min. T4 *Acanthamoeba* strains previously identified at our laboratory were used as a positive control and DNA-free water was used as a negative control. The amplicons were resolved by agarose-gel electrophoresis and visualized using ethidium-bromide.

Sequencing and genotyping of strains {#Sec5}
------------------------------------

PCR products were purified using a DNA band purification kit (Omega Bio-Tek, Omega, Norcross, GA, USA), according to manufacturer's instructions, and sequenced in both directions. The sequences of the PCR amplicons were obtained using the ABI PRISM BigDye Terminator Cycle Sequencing kit (Applied Biosystems, Foster City, CA, USA) with 5 pmol of JDP1 and JDP2 primers and a 310 ABI PRISM Genetic Analyzer.

Alignment and data exploration {#Sec6}
------------------------------

The sequences were assembled and edited with ALIGN, EditSeq and MegAlign (DNASTAR, Madison, WI, USA).

Phylogenetic analysis {#Sec7}
---------------------

The Bayesian inference algorithms implemented in MrBayes v.3.0B4 were used to infer phylogenetic trees \[[@CR14]\]. A total of 131 related nucleotide sequences of the *Rns* gene were selected considering an E-value close to zero and percentage identity \> 30% \[[@CR15]\].

The multiple alignment of the nucleotide sequences was performed in BioEdit and corrected in GeneDoc v.2.7.000 \[[@CR16]\]. After including gaps to maximize alignments, the final number of nucleotide positions was 459 bp. For the phylogenetic analysis, we used *Acanthamoeba* T14 (*Acanthamoeba* sp. AF333609 and AF333607) genotypes as outgroups, following to phylogenetic tree obtained by Risler et al. \[[@CR17]\]. In addition, we included genotypes T5 (*A. lenticulata* U94741), T2 (*Acanthamoeba* sp. AB425949; *Acanthamoeba polyphaga* ATCC30872, AY026244), T10 (*A. healyi* AF019070; *Acanthamoeba* sp. GU808320), T11 (*A. stevensoni* AF019069; *Acanthamoeba* sp. GU808311), T13 (*Acanthamoeba* sp. AY102615 and AF132136) and T16 (*Acanthamoeba* sp. AY026245 and GQ380408). The best-fitting model of nucleotide substitution was selected using the Bayesian information criterion implemented in the program MEGA v.7 \[[@CR18], [@CR19]\]. These results gave the best fit for the K2+Γ nucleotide substitution model \[[@CR20]\].

We simultaneously executed three parallel MCMC runs, each for 30 × 10^6^ generations with four Markov chains (one cold and three hot chains). Each run was analyzed in Tracer to confirm that effective sample sizes (ESS) were sufficient for all parameters (posterior ESS values \> 300) \[[@CR21]\]. The nodes were considered supported if posterior probabilities (PP) \> 0.95. The trees were visualized using FigTree v.1.1 available at <http://tree.bio.ed.ac.uk/software/figtree/> \[[@CR21]\].

Results {#Sec8}
=======

AK patients and samples {#Sec9}
-----------------------

A total of 114 *Acanthamoeba* isolates, obtained from 76 patients, were genotyped between 2005--2016. The total number of samples analyzed by culture method during the period, the number of positive samples obtained, the number of samples genotyped, and the gender of the patients in each category, are shown in Table [1](#Tab1){ref-type="table"}. The number of samples available for the analysis per patient ranged from one to four \[[@CR4]\]. Forty-nine patients were positive for *Acanthamoeba* in more than one sample, while 27 patients showed a positive culture only from a single sample (Table [2](#Tab2){ref-type="table"}). The *Acanthamoeba* isolates included in this study were obtained from both biological material (corneal scrape, biopsies and/or cotton swabs) and contact lens and its paraphernalia (contact lens boxes, lubricant and cleansing liquids).Table 1The number of samples and patients included in this studyTested^a^Positive^b^Genotyped^c^No. of patientsNo. of samplesNo. of patientsNo. of samplesNo. of patientsNo. of samplesFemale262377781015080Male15624751642634Total41862412916576114^a^The total number of samples and patients received at the ISP for *Acanthamoeba* screening between 2005--2016^b^The number of samples and patients that were found positive by culture^c^The number of positive samples and patients that were genotypedTable 2*Acanthamoeba* genotypes and accession numbers of the *Acanthamoeba* clinical strains isolated from Chilean patients with keratitis between 2005--2016Patient IDSample codeSexGenotypeGenBank IDPatient IDSample codeSexGenotypeGenBank ID1CHI1003MT4/EJF70287338CHI6806FT4/GJF7029052CHI1203MT4/AJF70287539CHI7506FT4/NJF7029073CHI1503MT4/MJF70287740CHI9006FT4/CJF7029104CHI1803FT4/BJF702879CHI9106T4/CMH1008495CHI3703FT4/AJF70289141CHI9306MT4/OJF702912CHI3803T4/AMH10082142CHI5007FT2KX688012CHI4103T4/AJF70289543CHI6007FT4/AKX688013CHI4203T4/AMH10082544CHI7007FT4/PKX6880146CHI4003FT4/AJF70289445CHI9007FT4/GKX6880157CHI4503MT4/AJF70289746CHI9507MT4/GKX6880168CHI4703MT4/AJF70289847CHI0608FT4/AKX6880179CHI5303FT4/AMH10083048CHI2808FT4/EKX688018CHI5403T4/AJF70290049CHI3408MT4/AKX68801910CHI56A03FT4/AMH10083450CHI4708MT4/DKX688020CHI56B03T4/AMH10083551CHI9608MT4/BKX688021CHI5603T4/AJF70290252CHI1309FT4/RKX68802211CHI2504FT4/QJF70288253CHI2809MT4/BKX68802312CHI3804FT4/CJF70289354CHI4309FT4/GKX688024CHI4004T4/CMH100822CHI4409T4/BKX68802513CHI5304MT4/CMH10083155CHI7509FT4/AKX688026CHI5404T4/CMH10083256CHI2810MT4/BKX688027CHI5504T4/CJF70290157CHI5010MT4/FKX68802814CHI5604FT4/AJF702903CHI5210T4/AKX68802915CHI5904FT4/DJF70290458CHI5910FT4/AKX68803016CHI7004FT4/DMH100839CHI6010T4/GKX688031CHI7204T4/DJF70290659CHI4011MT4/FKX68803517CHI8204FT4/HMH10084460CHI4411FT4/BKX688036CHI8304T4/HMH10084661CHI7011FT4/VKX688033CHI8404T4/HJF70290862CHI0112FT11KX68803718CHI8804FT4/AMH100847CHI0312T11KX688039CHI8904T4/AMH100848CHI0412T11KX688040CHI9004T4/AJF702909CHI0212T11KX68803819CHI9304FT4/AJF70291163CHI1812MT4/DKX68803420CHI0405MT4/AJF70287264CHI0615FT4/CMH10080721CHI1805MT4/AMH100814CHI0715T4/CMH100808CHI1905T4/AJF70288065CHI1815MT4/FMH10081622CHI2405FT4/AJF70288166CHI2515FT4/CMH100818CHI2505T4/AMH100817CHI2615T4/CMH100820CHI2605T4/AMH10081967CHI5015FT4/BMH10082723CHI2705FT4/AJF702883CHI5115T4/BMH10082924CHI3005FT4/AJF70288568CHI6715FT4/BMH10083825CHI3105FT4/AJF70288669CHI0416FT4/EMH10080526CHI3205FT4/GJF702887CHI0516T4/EMH10080627CHI3405FT11JF70288970CHI0716MT4/AMH10080928CHI3505FT4/MJF70289071CHI0916FT4/KMH10081029CHI3705MT4/AJF702892CHI1016T4/KMH10081130CHI4905FT4/AJF70289972CHI4016MT4/XMH10082331CHI1106MT4/AJF702874CHI4116T4/SMH10082432CHI1306MT4/DJF702876CHI4216T4/WMH100826CHI1506T4/DMH10081273CHI5016FT4/UMH10082833CHI1606FT4/AMH10081374CHI5416MT4/LMH100833CHI1706T4/AJF702878CHI6116T4/LMH100836CHI1806T4/AMH10081575CHI7016FT4/EMH10084134CHI2806FT4/IJF702884CHI7116T4/EMH10084235CHI3206MT4/AJF70288876CHI8116FT4/TMH10084336CHI4706FT4/HJF702896CHI8216T4/UMH10084537CHI6406BFT4/JJF702914CHI6506T4/JMH100837*Abbreviations*: *M* male, *F* female

Genotyping of the AK isolates and sequence analysis {#Sec10}
---------------------------------------------------

The molecular identification of the *Acanthamoeba* isolates was confirmed by the detection of the PCR fragment of the expected size for all isolates (423--551 bp). The sequences of the ASA.S1 amplicons obtained in this study have been deposited in the GenBank database (accession numbers are shown in Table [2](#Tab2){ref-type="table"}). By sequencing analysis of the DF3 region, 108 samples from the 73 patients were identified as genotype T4. Five strains from two patients were identified as *Acanthamoeba* sp. T11, while a single isolate obtained from a patient was identified as T2 genotype (Table [2](#Tab2){ref-type="table"}).

The subgenus classification of the T4 isolates was done by the sequence analysis of a 54--69 bp long variable region of the DF3, which revealed the presence of 24 sequence types, herein referred to as T4/A to X. The alignment of a highly variable section of the DF3 fragments showed four new sequence types (T4/L, S, T and U) that have not been previously described (Additional file [1](#MOESM1){ref-type="media"}: Table S1).

T4/A was the most prevalent sequence type being identified in 41 (38%) samples isolated from 28 (38.4%) patients. Furthermore, this T4/A variant was most frequent among the corneal scrape isolates (19 out of 55 samples, 35.6%). The sequence type T4/B was identified in isolates from 8 patients; the sequence types C and D were obtained from five patients each; sequence types E, F and G were isolated from 4, 3 and 6 patients, respectively; sequence types H, M and U were found in samples from 2 patients each; while the remaining sequence types were identified in isolates from individual patients.

Most of the samples obtained from the same patient had the same type of T4 variant; however, in five cases (patient IDs: 54, 57, 58, 72 and 76) the samples presented different variants.

Phylogenetic analysis {#Sec11}
---------------------

A total of 128 samples were included in this analysis (114 isolates obtained in this study and 14 reference strains; see methods). The phylogenetic tree constructed considering the partial sequence of the *Rns* gene (Fig. [1](#Fig1){ref-type="fig"}) was consistent with previous reports \[[@CR17]\]. The tree showed well-supported clusters for each of the genotypes (PP ≥ 0.95). The sequences from patient samples used in this study were clustered according to genotypes T2 (*n* = 1), T11 (*n* = 5), and T4 (*n* = 108).Fig. 1Phylogenetic tree based on the partial sequence of the *Rns* gene constructed using Bayesian inference analysis. The isolates from this study and reference *Acanthamoeba* strains are included

In relation to T4 genotype, the phylogenetic tree recovered three groups, two of them were well supported. The first group was weakly supported (PP = 0.52) and included the variants T4/C, D, I, L and Q. The second group (PP = 0.95) included variants T4H, J, O, P, R, T and U. Finally, the third group (PP = 0.95) included variants T4A, B, E, F, G, K, M, N, S, V, W and X.

Discussion {#Sec12}
==========

We genotyped 69.1% of the *Acanthamoeba* strains isolated at the ISPCh between 2005 and 2016, while the rest failed to revive after freezing. T4 was the predominant genotype found in Chilean isolates (73 out of 76 patients), as reported worldwide \[[@CR10], [@CR12], [@CR17], [@CR22]--[@CR24]\]. T4 is also the predominant genotype in environmental samples, followed by T5, both in Chile and other countries \[[@CR9], [@CR25], [@CR26]\]. None of our clinical isolates corresponded to genotype T5, further corroborating the observation that this genotype is clearly underrepresented in AK cases \[[@CR13]\]. In three other patients, T2 and T11 genotypes were found. Contrary to T4, these genotypes have rarely been found associated with AK \[[@CR12], [@CR27]--[@CR30]\]. Furthermore, in South America, genotype T11 has previously been reported only from the environmental samples, so this is the first report of this genotype being isolated from AK patients; it is also the first report of genotype T2 circulating in this area \[[@CR26], [@CR31]--[@CR33]\]. It is worth mentioning that the sequences of genotype T11 reported from the environmental strains in Chile are different from those isolated from AK patients \[[@CR26]\].

Among T4 isolates, 24 different DF3 sequence types from 108 isolates were identified in this study, herein referred to as T4/A to X. When comparing our DF3 sequences with those isolated from the environmental sources in a sole study of this type performed in Chile, only 3 out of 13 environmental sequences were the same as of ours \[[@CR26]\]. This finding suggests the existence of different degrees of virulence among genotype T4 strains, which warrants further investigation. Of our DF sequences, 38% belonged to the T4/A variant; the finding of this sequence variant as the most prevalent in Chile differs from that reported in other countries \[[@CR10], [@CR13], [@CR22], [@CR34]\]. Many of the remaining DF3 variants have previously been reported in more than 10 countries (T4E, F, G, I, N, O and V), while others have been reported in few countries, of even are described here for the first time. These data suggest the predominant worldwide distribution of some variants, along with some minor variants having a highly low distribution and, perhaps, weaker pathogenic properties. The Bayesian inference analysis further supports this classification, since most of the predominant and widely distributed variants were clustered together. Further studies should be conducted in order to elucidate what makes some variants more pathogenic than others. This information would also be valuable in order to select suitable strains for antigen production and development of diagnostic methods.

Finally, in most cases where more than one sample was available for culture, the same DF3 allele was isolated from all of them, following other authors \[[@CR13]\]. In discordant cases (5 out of 27), it is possible to assume that the infecting variant is the one found in the corneal scrape or the biopsy. In that sense, patient no. 72 was a particular case, providing different DF3 sequences between two corneal scrapes taken from the same eye, suggesting a truly mixed infection. Unfortunately, the low number of patients showing different variants precludes the analysis of a possible correlation between source and variant, which could provide an approximation of the real pathogenic potential of the different variants isolated.

Conclusions {#Sec13}
===========

We report for the first time the genotypes of AK causing strains circulating in Chile, obtained between 2005 and 2016. Chilean AK isolates were genotyped as T2, T4, and T11. 24 DF3 variants were identified within the predominant genotype T4. The Bayesian inference analysis showed that Chilean most prevalent T4 sub-genotypes, which have also been reported worldwide, formed a separate cluster of the minority or "local" T4 variants. This study provides useful information about the predominant genotypes and subgenotypes that would be useful in selecting suitable strains to develop immunological and/or molecular diagnostic assays in Chile.

Additional file
===============

 {#Sec14}

Additional file 1:**Table S1.** Primary sequence alignment of a highly variable section of the DF3. (DOCX 26 kb)

AK

:   *Acanthamoeba* keratitis

ASA.S1

:   *Acanthamoeba* specific amplimer

DF3

:   Diagnostic fragment 3

dNTP

:   Deoxynucleoside triphosphate

ISPCh

:   Public Health Institute of Chile

NNA-*E. coli*

:   Non-nutrient agar plates overlaid with live *Escherichia coli*

PCR

:   Polymerase chain reaction

*Rns*

:   Nuclear small subunit 18S ribosomal RNA gene
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